How do Clarivate Analytics and Publons propose to fortify peer review in the COVID-19 era?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Does the disconnect between the peer-reviewed label and reality explain the peer review crisis, and can open peer review or preprints resolve it? A narrative review.Naunyn-Schmiedeberg's archives of pharmacology · 2026
   Review
2. Research design and writing of scholarly articles: new artificial intelligence tools available for researchers.Endocrine · 2024
   Article
3. A Synthesis of the Formats for Correcting Erroneous and Fraudulent Academic Literature, and Associated Challenges.Journal for general philosophy of science = Zeitschrift fur allgemeine Wissenschaftstheorie · 2022
   Article
4. Peer Reviewers in Central Asia: Publons Based Analysis.Journal of Korean medical science · 2021
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.